Septerna Bolsters Leadership Team as the Company Advances its Multi-Product Pipeline Toward Clinical Studies

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Septerna, a biotechnology company discovering and advancing novel small molecule medicines targeting G protein-coupled receptors (GPCRs), today announced the addition of David Martin, Ph.D., as Senior Vice President of Development Sciences, and Samira Shaikhly as Chief People Officer to its leadership team. “As we continue to build both our product pipeline and our team, we know great leaders are critical to our continued success, and we’re excited

Recent Articles